Milton Capital Share Price (MII)

Interested to see how many senior ex- COPL folk are here sitting in a RTO vehicle. Focused team with an excellent deal making record. Surely they are looking at what is going on at COPL right now? Nick Pillar was senior O & G specialist at COPL in Wyoming for years and is at Milton now. Interesting team and talented one with so many connections to COPL ex CEO Arthur Millholland. Intriguing.

31st Oct 2023 7:00 am RNS Board Changes, Share Purchases and PDMR Dealings

"Board Changes, On-Market Share Purchases

and PDMR Dealings

HIGHLIGHTS

• Approximately £455,000 of existing shares purchased at 1.25p per share price by a range of new investors.

• 78.5% premium to the mid-market price at 30 October 2023

• 25% premium to October 2022 IPO issue price

• New Directors appointed with exceptional track records in the international oil and gas sector.

BACKGROUND

Milton Capital Plc is pleased to announce that certain other investors (the "Buyers") have agreed, via Peterhouse Capital, to acquire 36,400,000 existing ordinary shares through on- market purchases, at 1.25 pence per share, from a group of existing shareholders (the "Share Sales"). The selling shareholders include Malcolm Burne, a director of the Company, who has agreed to sell 12,000,000 ordinary shares as part of the Share Sales. Two of the Buyers, Edward Dawson and Richard Mays, who will join the board as Executive Director and Non-Executive Director respectively of the Company, with immediate effect, have each agreed to buy 4,000,000 ordinary shares in the Share Sales.

Eran Zucker, Executive Director, of the Company has decided to resign from the board as a director with immediate effect. Eran is not participating in the Share Sales and retains 1,999,900 ordinary shares, representing approximately 2.0% of the issued share capital.

In addition to the shares purchased as part of the Share Sales, the Buyers will also receive from the selling shareholders the two for one Investor Warrants that were attached to each ordinary share issued at the time of the Company's October 2022 IPO, as further detailed in the Company's Prospectus dated 29 September 2022.

Edward Dawson, incoming Executive Director stated: "I would like to place on record my thanks to Eran as a founding director of the Company. We are delighted he will retain his current shareholding in Milton as we embark on a new direction. We are excited about the array of [oil and gas/energy] opportunities that are presenting themselves and believe that the board will be able to use its expertise and contacts to seek out value enhancing opportunities in the sector. We look forward to updating shareholders as progress gets made." ..."

https://www.lse.co.uk/rns/MII/board-changes-share-purchases-and-pdmr-dealings-nf794ufiobqej6k.html

LSE % Gainers Top Lists

EPIC Name %

HUI Hydrogen Utopia +56%

RGD Real Good Food +50%

MII Milton Capital +48%

MII are up 48.3% today, rising 0.35p to 1.075p (1p - 1.15p), third on the top risers board.

20th Oct 2023 3:16 pm RNS Half-year Report

"Unaudited interim results for the period ended 31 July 2023

Milton Capital Plc ("Milton" or the "Company") is pleased to announce its interim results for the six months ending 31 July 2023 ("The Period").

The Interims Report will shortly be available to view on the Company's website.

Milton is a company incorporated and registered in England and Wales under the Companies Act 2006 and is a SPAC listed on the Standard segment of the London Stock Exchange. Milton was formed with the intention to identify and acquire a suitable business opportunity or opportunities and undertake an acquisition or merger or a series of acquisition or mergers. These Interim results have not been audited or reviewed by the Company's auditors.

Highlights:

• The Company recorded a loss before tax of £33,841 and had cash balances of £910,589 at the end of the period.

• Search for a suitable acquisition target continues.

Enquiries

Peterhouse Capital Limited

Financial Adviser

Guy Miller Tel: +44 (0) 20 7469 0930

Corporate Broker

Lucy Williams/ Duncan Vasey Tel: +44 (0) 20 7469 0930

CHAIRMAN'S STATEMENT

The past half-year has presented challenges in the capital markets due to the upward trend in interest rates, leading to a general slowdown in markets. The heightened uncertainties have made investors exercise caution, impacting our ability to identify a suitable RTO (Reverse Takeover) candidate. Nevertheless, we are confident in the Company's long-term prospects, and we are actively exploring all avenues to create shareholder value. During this period, we are committed to cost-efficiency, as we persist in our quest for a suitable acquisition target. Further updates regarding our acquisition search process will be provided in due time.

Malcolm Burne

Executive Director

Chairman ..."

https://www.lse.co.uk/rns/MII/half-year-report-r5ocj10cgfuzhe0.html

The shell company ASHI floated at 3p per share on 6th. June this year, market cap. £1.841M., compared to net cash of £717K., including its net IPO proceeds.

That didn't look cheap, but to its credit it has suspended (at 2.75p) for a DOUBLE RTO, valued at over £175M. including ASHI's shell value, just two and a half months later:-

17th Aug 2023 8:10 am RNS Heads of Terms Signed

"Heads of Terms Signed

Proposed Reverse Takeover of Cell Therapy Limited

Suspension of Listing

Conditional Acquisition of Cell Therapy Limited

Ashington Innovation (LSE:ASHI), the Special Purpose Acquisition Company (SPAC) established to acquire businesses primarily in the technology sector, is pleased to announce that the Company has entered into a non-binding term sheet (the "Term Sheet") with Cell Therapy Limited ("Cell Therapy") pursuant to which Ashington Innovation will acquire 100% of the total issued equity for £135 million in an all share transaction (the "Transaction"). Cell Therapy is a clinical stage biotechnology firm with a portfolio of patented cellular medicines with a lead program that successfully completed an early-stage human clinical trial in heart failure. ... "

https://www.lse.co.uk/rns/ASHI/heads-of-terms-signed-2z1etekcmhfmp97.html

24th Aug 2023 7:00 am RNS Heads of Terms Signed for the Acquisition of Calon

"Heads of Terms Signed for the Acquisition of Calon Cardio-Technology Limited, subject to the Completion of the Reverse Takeover of Cell Therapy Limited

Ashington Innovation plc (LSE: ASHI; FSE: 6FW), a special purpose acquisition company, is pleased to announce it has entered into a non-binding heads of terms agreement with Calon Cardio-Technology Limited ("Calon"), to acquire 100% of the outstanding shares in Calon in an all-share transaction. The acquisition is subject to the completion of the proposed reverse takeover of Cell Therapy Limited ("CTL") ...

Following recent discussions, on 23 August 2023 Ashington entered a non-binding heads of terms agreement with Calon for the acquisition of 100% of the issued share capital of Calon for a purchase price of £39 million ..."

https://www.lse.co.uk/rns/ASHI/heads-of-terms-signed-for-the-acquisition-of-calon-uxanjn1i7k94bxu.html

And no MII trade or volume showing for today.

Which I think makes the MII fall yesterday a clear-cut case of 'silly games' from the market makers.

Of course they may be hoping that a much wider spread (at the moment) puts off buyers. Though it doesn't have to.

Most shells are illiquid: but you can buy them with the intention of holding through suspension for the RTO.

After that, a £1M. market cap. can be transformed overnight into a £100M. market cap., and liquidity can follow suit.

But not all shell investors have that sort of sense and discipline, which is why you can get such significant shell undervaluations: if MII wasn't so illiquid, then it wouldn't be so cheap.